alexa Abstract | Delivery of Piroxicam With A Mucoadhesive Buccal Tablet: In Vitro, Ex Vivo and In Vivo Evaluation
e-ISSN:2320-1215 p-ISSN: 2322-0112

Research & Reviews in Pharmacy and Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


Piroxicam (PX) is one of the most potent non-steroidal, antiinflammatory agents which also exhibit anti-pyretic activity in various types of non-rheumatic pains. Although the drug is well absorbed following oral administration, gastric irritation is still the most serious adverse effect. Thus there is a need for an alternative drug delivery system with better GI tolerability. Buccal administration of drugs provides a convenient route of administration for both systemic and and local actions and bypasses first-pass effects and avoids GI side effects. Therefore the aim of this study was to develop buccal tablets of piroxicam by using hydroxypropyl methylcellulose and chitosan as mucoadhesive agents. Tablets were prepared with direct compression method and evaluated for physical properties. In vitro dissolution studies showed that the release rate of PX from the formulations affected by type and ratio of polymers. The release mechanism of PX from buccal tablets follows diffusive mechanism with first order and Higuchi release kinetics. In vivo studies of optimum buccal tablet formulation carried out on human healthy volunteers showed that the relative bioavailability of PX was 67.52 ± 21.47%. These results demonstrate that buccal tablet formulation of PX seems to be an alternative drug delivery for patients especially suffering from GI disturbances

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Ali Riza Kepsutlu, Cetin Tas, Ayhan Savaser, Yalcin Ozkan and Tamer Baykara


Piroxicam, Buccal tablet,Mucoadhesion, Chitosan, HPMC, Permeation, Piroxicam, Buccal tablet,Mucoadhesion, Chitosan, HPMC, Permeation.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version